News | Hemodynamic Support Devices | July 16, 2020

FDA Clears Data Streaming From the Impella Console to Allow Use of Artificial Intelligence Algorithms 

Abiomed said data streaming sets stage to further improve patient outcomes

The Abiomed Impella Connect allows data streaming from the Impella control consoles to the cloud, where the next step will be to apply predictive artificial intelligence (AI) algorithms.

Figure 1: The Abiomed Impella Connect allows data streaming from the Impella control consoles to the cloud, where the next step will be to apply predictive artificial intelligence (AI) algorithms.


July 16, 2020 – The U.S. Food and Drug Administration (FDA) approved one-way digital data streaming during patient support from Abiomed's Automated Impella Controller (AIC), the external console used with Impella heart pumps. The data streaming capability is facilitated through the Impella Connect interface, a HIPAA-compliant, cloud-based remote monitoring platform that is currently installed at more than 200 hospitals. The approval means console data could be streamed live via Impella Connect to a secure server where artificial intelligence (AI) could provide predictive clinical information to the patient’s physician. 

As an example of how this technology might be used in future clinical practice, Abiomed has already trained an AI algorithm to predict the next five minutes of a patient’s arterial pressure based only on the prior five minutes of console data. (See Figure 1) Abiomed has also developed AI algorithms to predict other parameters, such as stroke volume, left ventricular pressure and cardiac output. The AI algorithms are not yet cleared or approved for patient use. Once fully developed, the vendor will be submitted it for regulatory review.

Predictive analytics are possible by integrating Impella clinical study data with Impella console data from thousands of cases and training artificial intelligence networks on the co-registered data. AI networks could then receive and analyze console data in real-time and send patient-specific predictions to that patient’s medical provider. (See Figure 2)

Figure 2: Six cases of machine learning using Impella Console data to predict patient arterial pressures over the next five minutes.

Figure 2: Six cases of machine learning using Impella Console data to predict patient arterial pressures over the next five minutes.

“Artificial intelligence networks, properly trained using large volumes of streaming data, can be powerful tools to aid in clinical decision-making,” said Chuck Simonton, M.D., Abiomed’s chief medical officer. “One day, using artificial intelligence, physicians may be able to confidently predict a patient’s future hemodynamics. That would make clinical decision-making more efficient and improve patient outcomes.”

Abiomed is also studying artificial intelligence to make more holistic predictions, such as the probability a patient will recover his or her native heart function. This information could help medical providers determine if an alternative course of action is needed.

More information on the future direction of Impella technology, including the application of artificial intelligence, is available in this online presentation.

For more information: www.impella.com
 

Related Content

News | Hemodynamic Support Devices

November 12, 2020 — Abiomed recently announced new PROTECT III study data that demonstrates reduced rates of MACCE ...

Home November 12, 2020
Home
Videos | Hemodynamic Support Devices

Chuck Simonton, M.D., chief medical officer at Abiomed, discusses some of the new technologies and clinical trials the ...

Home October 20, 2020
Home
News | Hemodynamic Support Devices

October 16, 2020 — The Restore EF Study demonstrates the use of contemporary best practices, including attempting a more ...

Home October 16, 2020
Home
News | Hemodynamic Support Devices

June 5, 2020 — Abiomed announced the U.S. Food and Drug Administration (FDA) has approved the company's investigational ...

Home June 05, 2020
Home
Videos | Hemodynamic Support Devices

This is a quick animation demonstrating how the new 9 French Abiomed Impella ECP expands to approximately 18 French and ...

Home June 05, 2020
Home
Videos | Hemodynamic Support Devices

Interview with Navin Kapur, M.D., FAHA, FACC, FSCAI, executive director, The CardioVascular Center for Research and ...

Home February 07, 2020
Home
Videos | Hemodynamic Support Devices

Navin Kapur, M.D., FAHA, FACC, FSCAI, director, Acute Mechanical Circulatory Support Program and executive director of ...

Home January 24, 2020
Home
Videos | Hemodynamic Support Devices

Richard Botto, CVT, RCSA, chief cardiovascular technologist, division of cardiology, cardiac cath lab, and Melissa Smith ...

Home January 09, 2020
Home
News | Hemodynamic Support Devices

November 4, 2019 — Abbott is recalling its CentriMag Acute Circulatory Support System due to a calibration system error ...

Home November 04, 2019
Home
Subscribe Now